Investment Type: Venture Capital
Portfolio 1
Mentions in press and media 5
| Date | Title | Description |
| 19.03.2026 | German Biotech Kupando Secures €10M for Advanced Immunotherapy Pipeline | Kupando, a prominent German biotech firm, recently announced substantial new financing. The company secured an additional €10 million in Series A funding. This latest capital infusion elevates its total Series A funding to €23 million. The ... |
| 19.03.2026 | Kupando: €10 Million Series A Extension Raised By Biotech Company To Advance Immunotherapy Programs | Kupando, a Germany-based biotech company developing therapies for cancer and infectious diseases, has raised an additional €10 million in Series A funding, bringing the total to approximately $23 million. The financing was co-led by Remiges... |
| 18.03.2026 | Kupando Raises Additional €10M in Series A Funding | Kupando, a Schönefeld, Germany-based biotech company developing therapies for cancer and infectious diseases, raised additional €10M in Series A funding.
The round was co-led by Remiges Ventures, and LifeCare Partners, with participation fr... |
| 01.10.2022 | Kupando raises €13 million in Series A funding round | |
| 12.04.2021 | Remiges Ventures Closes Second Fund, at $95M; Launches RDiscovery Incubator | Remiges Ventures, a US-based cross-border venture capital firm with offices in Seattle, WA and Tokyo, Japan, closed its second fund, Remiges BioPharma Fund II, at $95m.
LPs include new and returning investors, such as Taiho Pharmaceutical C... |
Reviews 0
